14. Список литературы

Поставить закладку

Brown AK, Kim MH, Wu PYK, et al. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985;75:393.
Kaplan M, Hammerman C, Renbaum P, et al. Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates. Lancet 2000;356:652.
Gomella TL, Cunningham MD Neonatology: Management, Procedures, On Call Problems, Diseases, and Drugs. 7th Edition. 2013
Newman ТВ, Escobar GJ, Gonzales VM, et al. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics 1999; 104:1198.
Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near- term newborns. Pediatrics 1999; 103:6.
Maisels MJ, FanaroffAA Stevenson DK, et al. Serum bilirubin levels in an international, multiracial newborn population. Pediatr Res 1999;45:167A.
Ryan AS, Wenjun MS, Acosta A Breastfeeding continues to increase into the new millennium. Pediatrics 2002; 110:1103.
Cashore WJ, Gartner LM, Oh W, et al. Clinical application of neonatal bilirubin-binding determinations: current status. J Pecfafr" 1978;83:827.
Keren R, Tremont K, Luan X, et al. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed 2009;94:F317.
Maisels MJ, Pathak A, Nelson NM, et al. Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants. J Clin Invest 1971 ;50:1.
Ahdab-Barmada M. The neuropathology of kernicterus: definitions and debate. In: Maisels MJ, Watchko JF, eds. Neonatal jaundice. London, UK: Harwood Academic Publishers, 2000:75.
Turkel SB. Autopsy findings associated with neonatal hyperbilirubinemia. Clin Perinatol 1990;17:381.
Volpe JJ. Bilirubin and brain injury. In: Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia, PA W.B. Saunders, 2008:619
Wennberg RP, Ahlfors CE, Bhutani V, et al. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006; 117:474.
Bellarosa C, Muchova L, Vitek L, et al. Bilirubin metabolism and transport. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw Hill, 2012:55.
Hansen TWR, Bratlid D. Physiology of neonatal unconjugated hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw Hill, 2012:65
Kaplan M, Muraca M, Hammerman C, et al. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics 2002; 110(4).
Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J.Pediatrics 1999;103:6–14.
Brodersen R. Binding of bilirubin to albumin. CRC Crit Rev Clin Lab Sci 1980; 11:305
Maisels MJ, Newman ТВ. The epidemiology of neonatal hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw Hill, 2012:97
Watchko JF, Lin Z. Genetics of neonatal jaundice. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw Hill, 2012:1.
Engle WD, Jackson GL, Sendelbach D, et al. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics 2002; 110:61.
Bowman JM. The management of alloimmune fetal hemolytic disease. In: Maisels MJ, Watchko JF, eds. Neonatal jaundice. London, UK: Harwood Academic Publishers, 2000:23.
Koenig JM. Evaluation and treatment of erythroblastosis fetalis in the neonate. In: Christensen RD, ed. Hematologic problems ofthe neonate. Philadelphia, PA W.B. Saunders Co., 2000:185.
Bowman JM. Immune hemolytic disease. In: Nathan DG, Orkin SH, eds. Hematology of infancy and childhood, 5th ed. Philadelphia, PA: W.B. Saunders Company, 1998:54.
Bowman JM. RhD hemolytic disease of the newborn. N Engl J Med 1998;339:1775.
Rath MEA Smits-Wintjens VEHJ, Walther FJ, et al. Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization. Early Hum Dev 2011;87:583.
Ozolek J, Watchko J, Mimouni F. Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. J Pediatry 994; 125:87.
Maisels MJ. Neonatal Jaundice. In: Sinclair JC, Bracken MB, eds. Effective care of the newborn infant. Oxford, UK: Oxford University Press, 1992:507.
Newman ТВ, Liljestrand P, Escobar GJ. Jaundice noted in the first 24 hours after birth in a managed care organization. Arch Pediatr Adolesc Med 2002; 156:1244.
Knudsen A. Prediction ofthe development of neonatal jaundice by increased umbilical cord blood bilirubin. Acta Paediatr Scand 1989; 78:217.
Newman ТВ, Xiong B, Gonzales VM, et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr AdolescMed2000,IMA 140.
Maisels MJ, DeRidder JM, Kring EA, et al. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol 2009; 29:612.
Yamauchi Y, Yamanouchi I. Difference in TcB readings between full term newborn infants born vaginally and by cesarean section. Acta Paediatr Scand 1989;78:824.
Amato M, Fouchere JC, von Muralt G. Relationship between peri-intraventricular hemorrhage and neonatal hyperbilirubinemia in very low birth weight infants. Am J Perinatol 1987;4:275.
Silverman WA A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1998; 102:225 (supplement).
Keren R, Luan X, Friedman S, et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 2008; 121 :e170.
Bertini G, Dani C, Trochin M, etal. Is breastfeeding really favoring early neonatal jaundice? Pediatrics 2001;107.
Yamauchi Y, Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics 1990;86:171.
Gartner U, Goeser T, Wolkoff AW. Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology 1997; 113:1707.
Maisels MJ, Kring EA. Length of stay, jaundice and hospital readmission. Pediatrics 1998; 101:995.
McDonald SJ, Middleton P. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev 2008; 16(2):CD004074.
Saigal S, O'Neill A, Surainder Y, et al. Placental transfusion and hyperbilirubinemia in the premature. Pediatrics 1972;49:406.
Black VD, Lubchenco LO, Koops BL, et al. Neonatal hyperviscosity: randomized study of effect of partial plasma exchange transfusion on longterm outcome. Pediatrics 1985;75:1048
Goldberg K, Wirth FH, Hathaway WE, et al. Neonatal hyperviscosity II. Effect of partial plasma exchange transfusion. Pediatrics 1982;69:419.
Ultee CA, van der Deure J, Swart J, et al. Delayed cord clamping in preterm infants delivered at 34-36 weeks' gestation: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008;93(1 ):F20.
Frishberg Y, Zelicovic I, Merlob P, et al. Hyperbilirubinemia and influencing factors in term infants. IsrJ Med Sci 1989;25:28.
Jahrig D, Jahrig K, Striet S, et al. Neonatal jaundice in infants of diabetic mothers. Acta Paediatr Scand Suppl 1989;360:101.
Jahrig D, Jahrig K, Striet S, et al. Neonatal jaundice in infants of diabetic mothers. Acta Paediatr Scand Suppl 1989;360:101.
Berk MA Mimouni F, Miodovnik M, et al. Macrosomia in infants of insulin-dependent diabetic mothers. Pediatrics 1989;83:1029.
Chavalitdhamrong P-O, Escobedo MB, Barton LL, et al. Hyperbilirubinemia and bacterial infection in the newborn. Arch Dis Child 1975;50:652.
Linder N, Yatsiv I, Tsur M, etal. Unexplained neonatal jaundice as an early diagnostic sign ofsepticemia in the newborn. J Perinatol 1988;8:325.
Garcia FJ, Nager AL. Jaundice as an early diagnostic sign of urinary tract infection in infancy. Pediatrics 2002; 109: 6.
Maisels MJ, Newman ТВ. Neonatal jaundice and urinary tract infections. Pediatrics 2003^ 12:1213.
Kaplan M, Hammerman C. Hemolytic disorders and their management. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw Hill, 2012:145.
Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase-deficient neonates: a potential cause for concern in North America. Pediatrics 2000; 106:1478.
Kaplan M, Algur N, Hammerman C. Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2001; 108:956.
Kaplan M, Beutler E, Vreman HJ, et al. Neonatal hyperbilirubinemia in glucose-6- phosphate dehydrogenase deficient heterozygotes. Pediatrics 1999; 104:68.
Kaplan M, Hammerman C, Renbaum P, et al. Differing pathogenesis of perinatal bilirubinemia in glucose-6-phosphate dehydrogenase-deficient versus normal neonates. Pediatr Res 2001;50:532.
Bender GJ, Cashore WJ, Oh W. Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics 2007;'120:1067.
Ross ME, Waldron PE, Cashore WJ, et al. Hemolytic disease of the fetus and newborn. In: de Alarcon PA, Werner EJ, Christensen RD, eds. Neonatal hematology, pathogenesis, diagnosis, and management of hematologic problems, 2nd ed. Cambridge UK: Cambridge University Press, 2013:65.
Gallagher PG. Disorders of erythrocyte metabolism and shape. In: Christensen RD, ed. Hematologic problems of the neonate. Philadelphia, PA W.B. Saunders Co, 2000:209.
Christensen RD, Henry E. Hereditary spherocytosis in neonates with hyperbilirubinemia. Pediatrics 2010; 125:120.
Black VD, Lubchenco LO, Luckey DW, et al. Developmental and neurologic sequelae in the neonatal hyperviscosity syndrome. Pediatrics 1982;69:426.
Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinaemia in the era of genomics. Semin Neonatol 2002;7:143.
Kaplan M, Hammerman C, Maisels MJ. Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics 2003; 111:886.
Job H, Hart G, Lealman G. Improvements in long term phototherapy for patients with Crigler-Najjar syndrome type I. Phys Med Biol 1996;41 (11 ):2549.
Fox IJ, Roy-Chowdhury J, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422.
Vaz AR, Delgado-Esteban M, Brito MA, et al. Bilirubin selectively inhibits cytochrome с oxidase activity and induces apoptosis in immature cortical neurons: assessment of the protective effects of glycoursodeoxycholic acid. J Neurochem 2010; 112:56.
Wennberg RP. Cellular basis of bilirubin toxicity. NY State J Med 1991 ;91:493
Seidman DS, Paz I, Stevenson DK, et al. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics 1991 ;88:828.
Maisels MJ, Newman ТВ. Bilirubin and neurological dysfunction—do we need to change what we are doing? Pediatr Res 2001;50(6):677.
Grimmer I, Berger-Jones K, Buhrer C, et al. Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr 1999;88:661.
Heimler R, Sasidharan P. Neurodevelopmental and audiological outcome of healthy term newborns with moderately severe non-haemolytic hyperbilirubinemia. J Paediatr Child Health 2010;46:588.
Watchko JF, Tiribelli C., N Engl J Med. 2013 Nov;369(21):2021-30. Bilirubin-induced neurologic damage--mechanisms and management approaches.
Okumura A, Kidokoro H, Shoji H, et al. Kernicterus in preterm infants. Pecfafn'cs 2009; 123:e1052
Huang M-J, Kua K-E, Teng H-C, et al. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res 2004;56:682.
Cottrell BH, Anderson GC. Rectal or axillary temperature measurement: effect on plasma bilirubin and intestinal transit of meconium. J Pediatr Gastroenterol Nutr 1984;3:734
Knudsen A. The influence ofthe reserve albumin concentration and pH on the cephalocaudal progression of jaundice in newborns. Early Hum Dev 1991 ;25:37.
Watchko JF, Kaplan M, Stark AR, et al. Should we screen newborns for glucose-6- phosphate dehydrogenase deficiency in the United States? J Perinatol 2013;33:499.
Robertson A, Carp W, Broderson R. Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand 1991 ;80:1119.
Watchko JF, Maisels MJ. Jaundice in low birth weight infants—pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed2003;88:F455.
HackM, Wilson-Costello D, Friedman H, etal. Neurodevelopmentand predictors ofoutcomes ofchildren with birth weights ofless than 1000 g: 19921995. Arch Pediatr Adolesc Med2000; 154:725.
DeVries KL, Lary S, Dubowitz LMS. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 1985;76:351.
Morris BH, Oh W, Tyson JE, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 2008;359:1885.
Wagle S., Deshpande P.G., Itani O., Windle M.L., Clark D.A., Wagner C.l. Rosenkrantz T. Hemolytic Disease of Newborn. Updated: Sep 26, 2014. http://emedicine.medscape.com/article/974349)
Amin SB, Charafeddine L, Guillet R. Transient bilirubin encephalopathy and apnea of prematurity in 28 to 32 weeks gestational age infants. J Perinatol 2005;25:386.
Nakamura H, Takada S, Shimabuku R, et al. Auditory and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 1985;75:703.
Shapiro SM. Kernicterus. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care of the jaundiced neonate. New York, NY: McGraw Hill, 2012:229.
Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med2010;15:157.
Ip S, Glicken S, Kulig J, et al. Management of neonatal hyperbilirubinemia. Rockville, MD: U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality. AHRQ Publication, 200303.
Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present and future. Pediatrics 1992;90:707.
Johnson L, Brown AK, Bhutani VK. Bind—a clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics 1999;104:746.
Johnson L1, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009 Feb;29 Suppl 1:S25-45. doi: 10.1038/jp.2008.211.
Maisels MJ, Clune S, Coleman K, et al. The natural history of jaundice in predominantly breast-fed infants. Pediatrics 2014. doi: 10.1542/peds.2013- 4299
Davis AR, Rosenthal P, Escobar G, et al. Interpreting conjugated bilirubin levels in newborns. J Pediatr 2011; 158:562.
Maisels MJ, Baltz RD, Bhutani V, et al. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114:297.
Kramer LI. Advancement of Dermal Icterus in the Jaundiced Newborn. Amer J Dis Child. 1969; 118: 454-458
Maisels MJ, Bhutani VK, Bogen D, et al. Hyperbilirubinemia in the newborn infant > 35 weeks' gestation: an update with clarifications. Pediatrics 2009; 124(4):1193.
Jaundice in newborn babies under 28 days. Neonatal jaundice. National Institute for Health and Clinical Excellence, 2010;
Bhutani VK, Stark AR et al. Predischarge Screening for Severe Neonatal Hyperbilirubinemia Identifies Infants Who Need Phototherapy. Department of Neonatal and Developmental Medicine, Lucile Packard Children's Hospital, Department of Pediatrics, Stanford University, Stanford. Copyright ©2012
DeLuca D, Engle W, Jackson G. Transcutaneous bilirubinometry: hepatology research and clinical developments. New York: Nova Biomedical, 2013.
Schumacher R. Transcutaneous bilirubinometry and diagnostic tests: "The rightjob for the tool". Pediatrics 2002; 110:407.
Maisels MJ, Newman ТВ. Prevention, screening, and postnatal management of neonatal hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care of the jaundiced neonate. New York: McGraw Hill, 2012:175.
Wainer S, Rabi Y, Parmar SM, et al. Impact of skin tone on the performance of a transcutaneous jaundice meter. Acta Paediatr 2009; 98:1909.
Nagar G, Vandermeer B, Campbell S, et al. Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics 2013; 132:871.
De Luca D, Jackson GL, Tridente A, et al. Trans cutaneous bilirubin nomograms: a systematic review of population differences and analysis of bilirubin kinetics. Arch Pediatr Adolesc Med 2009; 163(11):1054.
Poland RL, Hartenberger C, McHenry H, et al. Comparison of skin sites for estimating serum total bilirubin in in-patients and out-patients: chest is superior to brow. J Perinatol 2004;24:541.
Yaser A, Tooke L, Rhoda N. Interscapular site for transcutaneous bilirubin measurement in preterm infants: a better and safer screening site. J Perinatol 2014;34:209.
Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 35 or more weeks' of gestation. Pediatrics 2006; 117:1169.
Tan KL, Dong F. Transcutaneous bilirubinometry during and after phototherapy. Acta Paediatr 2003;92:327.
Brumbaugh JE, Gourley GR. Bilirubin and its various fractions. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw Hill, 2012:41.
Eidelman Al, Schimmel MS, Algur N, et al. Capillary and venous bilirubin values: they are different—and how! Am J Dis Child 1989;143:642.
Glader B, Allen GA. Neonatal hemolysis. In: de Alarcon PA, Werner EJ, Christensen RD, eds. Neonatal hematology, pathogenesis, diagnosis, and management of hematologic problems, 2nd ed. Cambridge UK: Cambridge University Press, 2013:91.
Herschel M, Karrison T, Wen M, et al. Isoimmunization is unlikely to be the cause of hemolysis in ABO-lncompatible but direct antiglobulin testnegative neonates. Pediatrics 2002; 110:127.
Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics 2006; 118:276.
Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001; 108:31.
Mehta S, Kumar P, Narang A. A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr 2005;147:781.
Boo NY, Lee H-T. Randomized controlled trial of oral versus intravenous fluid supplementation on serum bilirubin level during phototherapy of term infants with severe hyperbilirubinemia. J Paediatr Child Health 2002;38:151.
M. Jeffrey Maisels, M.B., B.Ch., and Antony F. McDonagh, Ph.D. Phototherapy for Neonatal Jaundice. N Engl J Med 2008;358:920-8.
Maisels MJ, Newman ТВ. Phototherapy and other treatments. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw Hill, 2012:195.
Newman ТВ, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006;354:1889.
Steiner LA, Bizzarro MJ, Ehrenkranz RA, etal.A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 2007; 120:27.
Bhutani VK; Committee on Fetus and Newborn. Technical report: phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2011; 128:e1046.
Maisels MJ, Kring EA, DeRidder J. Randomized controlled trial of light-emitting diode phototherapy. J Perinatol 2007;27:565.
Subcommittee on hyperbilirubinaemia, American Academy of Pediatrics. Management ofhyperbilirubinaemia in the newborn infant 35 or more weeks of gestation, Clinical Practice Guideline. Pediatrics 2004, 114(1): 297-316.
Maisels MJ, Watchko JF, Bhutani VK, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol 2012;32:660.
Clinical practice guidline : Management of Hyperbilirubinemia in the Newborn Infant > 35 weeks of gestation Pediatrics 2004(July); 114:297
Watchko JF. Exchange transfusion in the management of neonatal hyperbilirubinemia. In: Maisels MJ, Watchko JF, eds. Neonatal jaundice. London, UK: Harwood Academic Publishers, 2000:169
Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114:e 130.
Rubaltelli FF, Zanardo V, Granati B. Effectofvarious phototherapy regimens on bilirubin decrement. Pediatrics 1978;61:838.
Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1997;99:e7.
Watchko JF. Exchange transfusion in the management of neonatal hyperbilirubinemia. In: Maisels MJ, Watchko JF, eds. Neonatal jaundice. London, UK: Harwood Academic Publishers, 2000:169
Patra K, Storfer-lsserA, Siner B, et al. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 2004\ 144:626
Norwegian guidelines for management of neonatal jaundice. Reproduced from Bratlid D, Nakstad B, Hansen TWR. National guidelines for treatment ofjaundice in the newborn. Acta Paediatr. 2011;100:499-505 455, 456, 376
Smits-Wintjens V.E.H.J., Walther F.J., Lopriore E. Rhesus haemolytic diseases of the newborn: Postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med. 2008; Vol.13: 265-71
Neonatal Jaundice/ Ed. Andrew Welsh. 2010. Royal College of Obstetricians and Gynaecologists
Rivers L.A., Heinig M.J. et. al. Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss// Pediatrics.- 2003. Vol.112. – P. 607-619
Barrington KJ, Sankaran K. Canadian Paediatric Society Fetus and Newborn Committee. Guidelines for the detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants. Paediatr Child Health. 2007;12(Suppl B):1B-12B.
Labrune P, Myara A, Huguet P, et al. Bilirubin uridine diphosphate glucuronosyltransferase hepatic activity in jaundice associated with congenital hypothyroidism. J Pediatr Gastroenterol Nutr 1992;14:79.
Trioche P, Chalas J, Francoual J, et al. Jaundice with hypertrophic pyloric stenosis as an early manifestation of Gilbert syndrome. Arch Dis Child 1999;81:301.
Таболин В. А. Билирубиновый обмен у новорожденных. М.: Медицина, 1967.
Гемолитическая болезнь плода и новорожденного. Савельева Г.М., Коноплянников А.Г., Курцер М.А., Панина О.Б., ГЭОТАР-Медиа М, 2011.
Шабалов Н.П. Неонатология (5-е издание). Учебное пособие в 2-х томах. ГЭОТАР-Медиа, 2016.
Неонатология. Национальное руководство. Краткая версия. /Под редакцией академика РАМН Володина Н.Н., ГЭОТАР-Медиа, 2013.
Сидельникова В.М., Антонов А.Г. Гемолитическая болезнь плода и новорожденного. «Триада-Х».- М.-2004.
Практическое руководство по неонатологии / Под ред. ГВ. Яцык. —М.: ООО «Медицинское информационное агентство», 2008.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница